Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-028003
Filing Date
2013-05-10
Accepted
2013-05-10 16:51:51
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v344560_10q.htm 10-Q 665765
2 EXHIBIT 31.1 v344560_ex31-1.htm EX-31.1 10592
3 EXHIBIT 31.2 v344560_ex31-2.htm EX-31.2 10546
4 EXHIBIT 32.1 v344560_ex32-1.htm EX-32.1 4325
5 EXHIBIT 32.2 v344560_ex32-2.htm EX-32.2 4335
  Complete submission text file 0001144204-13-028003.txt   11812835

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT scmp-20130331.xml EX-101.INS 2681282
7 XBRL TAXONOMY EXTENSION SCHEMA scmp-20130331.xsd EX-101.SCH 46215
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scmp-20130331_cal.xml EX-101.CAL 65031
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scmp-20130331_def.xml EX-101.DEF 196821
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE scmp-20130331_lab.xml EX-101.LAB 417192
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scmp-20130331_pre.xml EX-101.PRE 365398
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

EIN.: 133929237 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33609 | Film No.: 13834202
SIC: 2834 Pharmaceutical Preparations